Diego Ottaviani
Impact in
Papers in
- Co-authors
- Nicholas Fraser Brown (3 shared papers)Paul James Mulholland (3 shared papers)Denise Sheer (6 shared papers)Thomas Carter (1 shared paper)Neil D. Kitchen (1 shared paper)John Tazare (1 shared paper)John Gregson (1 shared paper)Naomi L. Fersht (1 shared paper)
- Journals
- Cancers (5 papers)Annals of Oncology (4 papers)The Lancet Oncology (3 papers)European Journal of Cancer (2 papers)Frontiers in Oncology (2 papers)
- Partner nations
- United KingdomSpainItaly
In The Last Decade
Diego Ottaviani
34 papers receiving 2.4k citations
Diego Ottaviani's Hit Papers
Peers
Comparison fields: 5 of 94
- Oncology 1.1k
- Genetics 296
- Infectious Diseases 448
- Hepatology 115
- Molecular Biology 418
Countries citing papers authored by Diego Ottaviani
This map shows the geographic impact of Diego Ottaviani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Ottaviani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Ottaviani more than expected).
Fields of papers citing papers by Diego Ottaviani
This network shows the impact of papers produced by Diego Ottaviani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Ottaviani. The network helps show where Diego Ottaviani may publish in the future.
Co-authors
The 25 scholars most cited alongside Diego Ottaviani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer Hit paper breakdown → | 2019 | 502 |
| 2 | COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study Hit paper breakdown → | 2020 | 450 |
| 3 | 2018 | 190 | |
| 4 | Survival Outcomes and Prognostic Factors in Glioblastoma Hit paper breakdown → | 2022 | 162 |
| 5 | 2020 | 153 | |
| 6 | 2014 | 145 | |
| 7 | 2019 | 115 | |
| 8 | 2021 | 92 | |
| 9 | 2011 | 87 | |
| 10 | 2022 | 67 | |
| 11 | 2021 | 60 | |
| 12 | 2021 | 54 | |
| 13 | 2020 | 53 | |
| 14 | 2008 | 48 | |
| 15 | 2022 | 45 | |
| 16 | 2021 | 42 | |
| 17 | 2021 | 30 | |
| 18 | 2022 | 28 | |
| 19 | 2022 | 26 | |
| 20 | 2008 | 22 |
About Diego Ottaviani
Diego Ottaviani is a scholar working on Oncology, Genetics, Infectious Diseases, Cancer Research and Molecular Biology, having authored 38 papers that have together received 2.5k indexed citations. Recurring topics across this work include COVID-19 and healthcare impacts (14 papers), Glioma Diagnosis and Treatment (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), COVID-19 Clinical Research Studies (3 papers), Genomics and Chromatin Dynamics (2 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers), Breast Cancer Treatment Studies (2 papers) and Palliative Care and End-of-Life Issues (2 papers). The work is most often cited by research in Oncology (1.1k citations), Genetics (296 citations), Infectious Diseases (448 citations), Hepatology (115 citations) and Molecular Biology (418 citations). Diego Ottaviani has collaborated with scholars based in United Kingdom, Spain and Italy. Frequent co-authors include Nicholas Fraser Brown, Paul James Mulholland, Denise Sheer, Thomas Carter, Neil D. Kitchen, John Tazare, John Gregson, Naomi L. Fersht, Sebastian Brandner and Elliott Lever. Their work appears in journals such as Cancers, Annals of Oncology, The Lancet Oncology, European Journal of Cancer and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.